Siemens Healthineers AG (SHL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Siemens Healthineers AG (SHL) has a cash flow conversion efficiency ratio of 0.064x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€1.23 Billion ≈ $1.44 Billion USD) by net assets (€19.16 Billion ≈ $22.40 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SHL market cap overview for the company's overall valuation and market capitalisation.
Siemens Healthineers AG - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Siemens Healthineers AG's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Siemens Healthineers AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Siemens Healthineers AG ranked by their cash flow conversion efficiency. Explore SHL cash flow quality score to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CTBC Financial Holding Co Ltd
TW:2891
|
0.246x |
|
AngloGold Ashanti Ltd
JSE:ANG
|
0.133x |
|
RIO Tinto Ltd
AU:RIO
|
0.151x |
|
STANDARD CHART.UNSP.ADR/2
F:STD0
|
N/A |
|
Cardinal Health Inc
NYSE:CAH
|
-0.682x |
|
ST GOBAIN ADR 1/5/EO 4
F:GOBU
|
N/A |
|
Semiconductor Manufacturing Intl Co
SHG:688981
|
0.028x |
|
HEINEKEN SP. ADR 1/2
F:HNK2
|
N/A |
Annual Cash Flow Conversion Efficiency for Siemens Healthineers AG (2017–2024)
The table below shows the annual cash flow conversion efficiency of Siemens Healthineers AG from 2017 to 2024. View SHL stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-09-30 | €18.25 Billion ≈ $21.33 Billion |
€2.83 Billion ≈ $3.30 Billion |
0.155x | +32.52% |
| 2023-09-30 | €18.13 Billion ≈ $21.20 Billion |
€2.12 Billion ≈ $2.48 Billion |
0.117x | -7.35% |
| 2022-09-30 | €19.85 Billion ≈ $23.21 Billion |
€2.50 Billion ≈ $2.93 Billion |
0.126x | -29.73% |
| 2021-09-30 | €16.34 Billion ≈ $19.10 Billion |
€2.93 Billion ≈ $3.43 Billion |
0.180x | +16.49% |
| 2020-09-30 | €12.51 Billion ≈ $14.63 Billion |
€1.93 Billion ≈ $2.25 Billion |
0.154x | -6.77% |
| 2019-09-30 | €9.78 Billion ≈ $11.44 Billion |
€1.62 Billion ≈ $1.89 Billion |
0.165x | -10.08% |
| 2018-09-30 | €8.68 Billion ≈ $10.14 Billion |
€1.59 Billion ≈ $1.86 Billion |
0.184x | -69.82% |
| 2017-09-30 | €3.24 Billion ≈ $3.79 Billion |
€1.98 Billion ≈ $2.31 Billion |
0.609x | -- |
About Siemens Healthineers AG
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment… Read more